Cite
Liu Y, O'Leary CE, Wang LS, et al. CD11b+Ly6G+ cells inhibit tumor growth by suppressing IL-17 production at early stages of tumorigenesis. Oncoimmunology. 2015;5(1):e1061175doi: 10.1080/2162402X.2015.1061175.
Liu, Y., O'Leary, C. E., Wang, L. S., Bhatti, T. R., Dai, N., Kapoor, V., Liu, P., Mei, J., Guo, L., Oliver, P. M., Albelda, S. M., & Worthen, G. S. (2016). CD11b+Ly6G+ cells inhibit tumor growth by suppressing IL-17 production at early stages of tumorigenesis. Oncoimmunology, 5(1), e1061175. https://doi.org/10.1080/2162402X.2015.1061175
Liu, Yuhong, et al. "CD11b+Ly6G+ cells inhibit tumor growth by suppressing IL-17 production at early stages of tumorigenesis." Oncoimmunology vol. 5,1 (2016): e1061175. doi: https://doi.org/10.1080/2162402X.2015.1061175
Liu Y, O'Leary CE, Wang LS, Bhatti TR, Dai N, Kapoor V, Liu P, Mei J, Guo L, Oliver PM, Albelda SM, Worthen GS. CD11b+Ly6G+ cells inhibit tumor growth by suppressing IL-17 production at early stages of tumorigenesis. Oncoimmunology. 2015 Jul 28;5(1):e1061175. doi: 10.1080/2162402X.2015.1061175. eCollection 2016. PMID: 26942073; PMCID: PMC4760327.
Copy
Download .nbib